HKSE:02453 (China)
Â
Ordinary Shares - Class H
HK$
6.86
-0.11 (-1.58%)
Apr 25
What is a stock summary page? Click here for an overview.
Business Description
Concord Healthcare Group Co Ltd
ISIN : CNE100006BL7
Share Class Description:
HKSE:02453: Ordinary Shares - Class HCompare
Compare
Traded in other countries / regions
02453.Hong Kong Index Membership
Hong Kong Stock Connect IPO Date
2024-01-09Description
Concord Healthcare Group Co Ltd is a healthcare service provider in China that specializes in oncology. The company caters to both cancer patients and third-party medical institutions. It operates its own medical institutions to provide comprehensive oncology healthcare services to cancer patients using its medical professionals and advanced precision radiation therapy. It also provides medical equipment, software, and related services to third-party medical institutions. The company's revenue is primarily generated from its hospital business and its medical equipment, software, and related services segment.
Financial Strength
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 0.11 | |||||
| Equity-to-Asset | 0.28 | |||||
| Debt-to-Equity | 1.95 | |||||
| Debt-to-EBITDA | -10.59 | |||||
| Piotroski F-Score | 3/9 | |||||
| Altman Z-Score | 0.4 | |||||
| Beneish M-Score | -2.68 | |||||
| WACC vs ROIC | ||||||
Growth Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -10.4 | |||||
| 3-Year EBITDA Growth Rate | -4.6 | |||||
| 3-Year EPS without NRI Growth Rate | 22.6 | |||||
| 3-Year FCF Growth Rate | 24.1 |
Momentum Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 53.44 | |||||
| 9-Day RSI | 50.06 | |||||
| 14-Day RSI | 47.17 | |||||
| 3-1 Month Momentum % | 2.04 | |||||
| 6-1 Month Momentum % | -52.35 | |||||
| 12-1 Month Momentum % | -78.48 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 0.63 | |||||
| Quick Ratio | 0.6 | |||||
| Cash Ratio | 0.3 | |||||
| Days Inventory | 30.56 | |||||
| Days Sales Outstanding | 62.31 | |||||
| Days Payable | 96.94 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Shareholder Yield % | -8.62 |
Profitability Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | -17.31 | |||||
| Operating Margin % | -108.48 | |||||
| Net Margin % | -114 | |||||
| FCF Margin % | -91.48 | |||||
| ROE % | -25.62 | |||||
| ROA % | -7.83 | |||||
| ROIC % | -6.92 | |||||
| 3-Year ROIIC % | -0.62 | |||||
| ROC (Joel Greenblatt) % | -10.07 | |||||
| ROCE % | -8.48 |
GF Value Rank
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 11.81 | |||||
| PB Ratio | 2.79 | |||||
| Price-to-Tangible-Book | 5.62 | |||||
| EV-to-EBIT | -20.6 | |||||
| EV-to-EBITDA | -25.68 | |||||
| EV-to-Revenue | 19.95 | |||||
| EV-to-FCF | -20.49 | |||||
| Earnings Yield (Greenblatt) % | -4.85 | |||||
| FCF Yield % | -7.75 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Concord Healthcare Group Co Ltd Executives
DetailsGF Value
Analyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil HK$) | 416.525 | ||
| EPS (TTM) (HK$) | -0.664 | ||
| Beta | - | ||
| 3-Year Sharpe Ratio | - | ||
| 3-Year Sortino Ratio | - | ||
| Volatility % | 120.18 | ||
| 14-Day RSI | 47.17 | ||
| 14-Day ATR (HK$) | 0.600817 | ||
| 20-Day SMA (HK$) | 6.8065 | ||
| 12-1 Month Momentum % | -78.48 | ||
| 52-Week Range (HK$) | 5.77 - 55 | ||
| Shares Outstanding (Mil) | 716.34 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 3 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Concord Healthcare Group Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Concord Healthcare Group Co Ltd Stock Events
| Event | Date | Price (HK$) | ||
|---|---|---|---|---|
| No Event Data | ||||
Concord Healthcare Group Co Ltd Frequently Asked Questions
What is Concord Healthcare Group Co Ltd(HKSE:02453)'s stock price today?
The current price of HKSE:02453 is HK$6.86. The 52 week high of HKSE:02453 is HK$55.00 and 52 week low is HK$5.77.
When is next earnings date of Concord Healthcare Group Co Ltd(HKSE:02453)?
The next earnings date of Concord Healthcare Group Co Ltd(HKSE:02453) is .
Does Concord Healthcare Group Co Ltd(HKSE:02453) pay dividends? If so, how much?
Concord Healthcare Group Co Ltd(HKSE:02453) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers